AI-assisted CT scan to assess heart artery disease risk
Part of Heart & circulation clinical trials.
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor has already recommended a heart CT scan for clinical reasons
- You are able and willing to give informed consent (understand and agree to participate)
- You do not have a history of cancer
- Your kidney function is normal or within a safe range for contrast dye
- You can safely receive iodinated contrast (dye used during CT scans) and have no contraindications to CT imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI system can detect signs of coronary artery disease (blockages in heart arteries) by analyzing a photo of your face. It may help identify people in the community who need further heart testing.
This study uses artificial intelligence to look for signs of heart artery disease on a CT scan that doesn't require dye. It's for people with stable chest pain who have already had a specific type of CT scan.
This trial uses an artificial intelligence (AI) tool to analyze heart CT scans (CCTA) and identify dangerous plaque buildup that could lead to a heart attack. It aims to see if AI can better predict high-risk plaques in people with known or suspected coronary artery disease (CAD).
This trial tests whether an artificial intelligence program can help doctors interpret heart CT scans faster and more accurately for people with chest pain in the emergency room. If you come to the ER with chest pain and are at intermediate risk, this study may help improve your care.
This study uses a CT scan of your heart (CCTA) and advanced computer analysis to see how well it can predict heart risks compared to detailed inside-look tests (IVUS, OCT, NIRS). If you have chest pain and have had certain heart scans, this trial may help doctors understand your condition better.
This study uses artificial intelligence to look at CT scans of the heart to find which fatty deposits (plaque) in the arteries might be dangerous. It may help doctors better predict heart attacks.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.